×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5B: Are Inspections a Necessary Distraction or a Welcome Opportunity for Improvement?
Session Chair(s)
Claire Longman, MSc
Expert Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Angela Van Der Salm, PhD, MSc
Director PV, Managing partner
DADA Consultancy B.V., Netherlands
Session 5: Are Inspections a Necessary Distraction or a Welcome Opportunity for Improvement?
Speaker(s)
Panel Discussion
Claire Longman, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Pharmacovigilance Inspector
Panel Discussion
Walaa Ebrahim
Egyptian Drug Authority, Egypt
Head of Egyptian Pharmaceutical Vigilence Center
Panel Discussion
Jean Kilgour-Christie, BSN, MSc
Sandoz International GmbH, Germany
Deputy EU QPPV Head, UK QPPV
Have an account?